Guidelines for Addressing Benzodiazepine Use in Opioid Treatment Programs (OTPs)

April 20th, 2017

Earlier this month, the American Association for the Treatment of Opioid Dependence (AATOD) released its long-awaited report, Guidelines for Addressing Benzodiazepine Use in Opioid Treatment Programs (OTPs). The purpose of the AATOD report is to offer guidance, instead of restrictive procedures, to help OTPs treat these patients. The report notes that both careful monitoring and coordination of care that is “respectful but not capricious or punitive” are essential to ensure safe, effective, and individualized care for OTP patients.

Download AATODs Benzodiazepine Guidelines

Posted in Content


A Project of the Governor's Institute on Alcohol & Substance Abuse and the North Carolina Society of Addiction Medicine.
Funded wholly or in part by the federal Substance Abuse Prevention and Treatment Block Grant Fund (CFDA #93.959) as a project of the NC Division of Mental Health, Developmental Disabilities & Substance Abuse Services.